» Articles » PMID: 14987995

Mitotic Phosphorylation of Histone H3 at Threonine 3

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2004 Feb 28
PMID 14987995
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Nuclear envelope-peripheral heterochromatin fractions contain multiple histone kinase activities. In vitro assays and amino-terminal sequencing show that one of these activities co-isolates with heterochromatin protein 1 (HP1) and phosphorylates histone H3 at threonine 3. Antibodies recognizing this post-translational modification reveal that in vivo phosphorylation at threonine 3 commences at early prophase in the vicinity of the nuclear envelope, spreads to pericentromeric chromatin during prometaphase and is fully reversed by late anaphase. This spatio-temporal pattern is distinct from H3 phosphorylation at serine 10, which also occurs during cell division, suggesting segregation of differentially phosphorylated chromatin to different regions of mitotic chromosomes.

Citing Articles

Haspin kinase binds to a nucleosomal DNA supergroove.

Hicks C, Gliech C, Rahman S, Zhang X, Eneim A, Vasquez S Nat Struct Mol Biol. 2025; .

PMID: 39979508 DOI: 10.1038/s41594-025-01502-y.


Haspin mediates H3.3S31 phosphorylation downstream of Aurora B in mouse embryonic stem cells.

Li Y, Wu M, Liu Y, Sun L, Mu P, Ma B Protein Sci. 2024; 33(8):e5126.

PMID: 39073155 PMC: 11284449. DOI: 10.1002/pro.5126.


Dissecting the roles of Haspin and VRK1 in histone H3 phosphorylation during mitosis.

Cartwright T, Harris R, Meyer S, Mon A, Watson N, Tan C Sci Rep. 2022; 12(1):11210.

PMID: 35778595 PMC: 9249732. DOI: 10.1038/s41598-022-15339-8.


Multivalent DNA and nucleosome acidic patch interactions specify VRK1 mitotic localization and activity.

Budziszewski G, Zhao Y, Spangler C, Kedziora K, Williams M, Azzam D Nucleic Acids Res. 2022; 50(8):4355-4371.

PMID: 35390161 PMC: 9071384. DOI: 10.1093/nar/gkac198.


The Role of Histone Post-Translational Modifications in Merkel Cell Carcinoma.

Mazziotta C, Lanzillotti C, Gafa R, Touze A, Durand M, Martini F Front Oncol. 2022; 12:832047.

PMID: 35350569 PMC: 8957841. DOI: 10.3389/fonc.2022.832047.